India Pesticides Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ux29h8aduj0iwhvsz0xok7oy.pdf

Key Takeaways


China-Led Pricing Pressure & Volume Strategy

D.K. Jain: "Pricing pressure from China still continues because they are trying to dump the material as much as possible at unreasonable prices. But we are also well equipped now to take on the Chinese competition."

Hamirpur: The Multi-Year Capacity Build

D.K. Jain: "Ultimately, we would be spending another Rs.200 crores - Rs.300 crores in our Hamirpur facility, because we will be building this facility block by block... we feel that there is a scope of adding almost 10, 11 blocks."

Formulation: The Domestic Growth Bet

D.K. Jain: "Formulation growth also would be similar, at least 20% per year. And India has been growing almost 9% to 10% per year overall consumption... we plan to have more than 20% increase every year."

Margin Recovery: Efficiency, Not Pricing

D.K. Jain: "We are focusing now on our process optimization. And that work our R&D team is doing continuously day in and day out, and we have achieved some success during this quarter."

Regulatory & Customer Access Wins

D.K. Jain: "That company is a very big company, we expect good volumes and good products from them in the coming future."

Inventory & Working Capital


Guidance & Commitments

CommitmentSpecificsTimeline
Hamirpur first revenueFirst block commissioned, targeting ₹50-60 crores combined from two blocksQ1 FY26 (block 1), Q2 FY26 (block 2)
Hamirpur long-term capacity₹700-800 crores revenue from up to 10-11 blocks, built at ~2 blocks/year3-4 years
Existing plant revenue growth15-20% increase from existing plantsFY26
Formulation growthAt least 20% per yearOngoing annual target
H2 EBITDA margin18-20%, contingent on stable raw material pricesH2 FY25
FY25 capex₹110 crores (IPL + SSL combined), funded internallyFY25
Inventory days normalization120-130 daysBy March 2025
European insecticide salesRevenue conversion after customers obtain permissions (2-3 months)Q4 FY25 / Q1 FY26
Japanese customer onboardingFirst purchases expectedJanuary/February 2025
Sandila formulation expansion~2,000 tonnes added to existing ~3,000 tonnesFY25

Key Metrics

MetricQ2 FY25
Revenue₹234 crores, +13.6% YoY and +4.5% QoQ
EBITDA₹39 crores, +25.2% YoY; EBITDA margin at 16.6%
Net profit₹26 crores, +32.9% YoY
Domestic revenue₹155 crores
Export revenue₹74 crores
Technical sales₹131 crores, flat YoY (₹139 crores in Q2 FY24)
Formulations sales₹98 crores
Technical volume growth~30% YoY
Blended price decline~19% to 20% YoY
H1 FY25 revenue₹458 crores, +11% YoY
H1 FY25 EBITDA₹71 crores, vs ₹57 crores in H1 FY24
Cash and cash equivalents₹127 crores at quarter-end
FY25 capex target₹110 crores (₹50 crores Sandila, ₹60 crores Hamirpur)
Inventory days~150 days, expected to normalize to 120–130 days by March
Sandila capacity utilization~60% to 65%